Avalo Therapeutics, Inc. Common Stock Share Price
NASDAQ: AVTXHealthcare
Live Avalo Therapeutics, Inc. Common Stock Share Price Chart
O H L
Avalo Therapeutics, Inc. Common Stock Performance Overview
Days Range
▼
$16.47Low
$16.51High
Markets Today
| Previous Close | $16.69 |
|---|---|
| Open | $16.50 |
| Volume | 81,153 |
| Day's Range | $16.47 - $16.51 |
| 52W Range | $9.84 - $24.27 |
| Market Cap | $889.19 M |
Historical Performance
| 1M Returns | -15.32 |
|---|---|
| 3M Returns | +13.54 |
| 6M Returns | +13.69 |
| 1Y Returns | +40.49 |
| 5Y Returns | -99.77 |
| 10Y Returns | NA |
Avalo Therapeutics, Inc. Common Stock Fundamentals
| Market Cap | $889.19 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $59.00 K |
| ROE TTM | -0.72 |
| EPS TTM | $-4.75 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 1.95 |
| EBITDA | $-72.58 M |
| Profit Margin | -132642.37 |
| Market Cap | $889.19 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $59.00 K |
| ROE TTM | -0.72 |
| EPS TTM | $-4.75 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 1.95 |
| EBITDA | $-72.58 M |
| Profit Margin | -132642.37 |
Avalo Therapeutics, Inc. Common Stock Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $0 | $0 | $0 | $59.00 K | $0 | $0 |
| Gross Profit + | $0 | $0 | $0 | $59.00 K | $0 | $0 |
| Operating Income | -$14.67 M | -$19.32 M | -$19.20 M | -$19.74 M | -$20.90 M | -$31.52 M |
| EBITDA | -$14.53 M | -$19.18 M | -$19.14 M | -$19.73 M | -$20.88 M | -$31.50 M |
| Interest Expense | $1.15 M | $1.10 M | $0 | $0 | $803.00 K | $2.76 M |
| Depreciation | $135.00 K | $134.00 K | $59.00 K | $16.00 K | $17.00 K | $17.00 K |
| Income Before Tax | -$13.14 M | -$20.75 M | -$30.61 M | -$13.59 M | -$19.62 M | -$36.34 M |
| Income Tax Expense | $8.00 K | $16.00 K | $11.00 K | $130.00 K | $12.00 K | $18.00 K |
| Net Income + | -$13.15 M | -$20.77 M | -$30.63 M | -$13.72 M | -$19.63 M | -$36.36 M |
| Net Profit Margin | - | - | - | -23254.24% | - | - |
Avalo Therapeutics, Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $11.00 K | $11.00 K | $18.00 K | $18.00 K | $25.00 K | $53.00 K |
| Reserve & Surplus | -$383.41 M | -$404.21 M | -$434.76 M | -$448.45 M | -$468.16 M | -$505.09 M |
| Non-Current Liabilities | $10.29 M | $12.75 M | $25.58 M | $20.47 M | $19.97 M | $20.99 M |
| Current Liabilities | $5.62 M | $9.26 M | $7.97 M | $12.94 M | $11.60 M | $21.13 M |
| Total Liabilities | $15.91 M | $22.01 M | $33.55 M | $33.41 M | $31.57 M | $42.12 M |
| Fixed Assets | $949.00 K | $686.00 K | $542.00 K | $460.00 K | $375.00 K | $288.00 K |
| Current Assets | $126.94 M | $115.19 M | $113.85 M | $105.29 M | $88.83 M | $407.93 M |
| Total Assets | $138.52 M | $126.58 M | $125.10 M | $116.46 M | $99.89 M | $490.78 M |
Avalo Therapeutics, Inc. Common Stock Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$13.15 M | -$20.77 M | -$30.63 M | -$13.72 M | -$19.63 M | -$36.36 M |
| Operating Cash Flow | -$9.46 M | -$11.39 M | -$16.36 M | -$14.25 M | -$17.69 M | -$19.99 M |
| Investing Cash Flow | $0 | -$70.86 M | -$13.26 M | $2.40 M | $25.50 M | -$329.93 M |
| Financing Cash Flow | $0 | -$469.00 K | $14.37 M | $687.00 K | $1.40 M | $410.21 M |
| Change in Cash | -$9.46 M | -$82.72 M | -$15.26 M | -$11.16 M | $9.21 M | $60.30 M |
Avalo Therapeutics, Inc. Common Stock Return Calculator
The Avalo Therapeutics, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$22
Invested Amount$10,000
Est. Returns$-9,978
About Avalo Therapeutics, Inc. Common Stock
Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.
Popular Stocks
FAQs
What is the share price of Avalo Therapeutics, Inc. Common Stock today?
Avalo Therapeutics, Inc. Common Stock (AVTX) share price as of September 18, 2026 is $16.27. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Avalo Therapeutics, Inc. Common Stock?
Yes, Indian Investors can invest in the Avalo Therapeutics, Inc. Common Stock (AVTX) Share by opening an international trading account with Angel One.
How can I purchase Avalo Therapeutics, Inc. Common Stock shares in India?
Purchasing Avalo Therapeutics, Inc. Common Stock (AVTX) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Avalo Therapeutics, Inc. Common Stock (AVTX) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Avalo Therapeutics, Inc. Common Stock?
Yes, you can purchase fractional shares of Avalo Therapeutics, Inc. Common Stock (AVTX) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Avalo Therapeutics, Inc. Common Stock?
The market capitalization of Avalo Therapeutics, Inc. Common Stock on September 18, 2026, is $889.19 M.
In which sector Avalo Therapeutics, Inc. Common Stock belongs?
Avalo Therapeutics, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Avalo Therapeutics, Inc. Common Stock stocks?
In order to invest in Avalo Therapeutics, Inc. Common Stock (AVTX) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
